Sign in Sign up for free

Last updated: 10 February 2020 at 5:23pm EST

Erin Moore Net Worth



Erin Moore biography

Erin Moore serves as Senior Vice President - Finance of the Company. She previously as our Vice President, Finance & Controller beginning in October 2018. Prior to joining us, Ms. Moore served as Controller, Senior Director of Accounting at Synlogic, Inc. from September 2016 to October 2018 where she built the accounting department and established processes and procedures to support accounting operations for a rapidly growing company and its public offerings. Prior to Synlogic, Inc., from March 2015 to September 2016, Ms. Moore served as Director of Accounting at Abiomed, Inc. From December 2012 to March 2015, Ms. Moore served as Director of Accounting at GI Dynamics, Inc. From August 2006 to December 2012, Ms. Moore held various roles of increasing responsibility in accounting at Ironwood Pharmaceuticals. Ms. Moore is a Certified Public Accountant and holds a M.S. in Accounting from Bentley College, a M.S. in Environmental Management and Economics from Johns Hopkins University and a B.A. from Clark University.



How old is Erin Moore?

Erin Moore is 45, she's been the Senior Vice President - Finance of Scholar Rock Corp since 2019. There are 9 older and 2 younger executives at Scholar Rock Corp. The oldest executive at Scholar Rock Holding Corp is Michael Gilman, 65, who is the Independent Director.

What's Erin Moore's mailing address?

Erin's mailing address filed with the SEC is 620 MEMORIAL DRIVE, 2ND FLOOR, , CAMBRIDGE, MA, 02139.

Insiders trading at Scholar Rock Corp

Over the last 6 years, insiders at Scholar Rock Corp have traded over $8,613,447 worth of Scholar Rock Corp stock and bought 8,895,194 units worth $64,726,758 . The most active insiders traders include Timothy A Springer, Srinivas Akkaraju, and Amir Nashat. On average, Scholar Rock Corp executives and independent directors trade stock every 55 days with the average trade being worth of $1,953,616. The most recent stock trade was executed by Caryn Parlavecchio on 16 August 2024, trading 1,451 units of SRRK stock currently worth $13,538.



What does Scholar Rock Corp do?

scholar rock® is a biotechnology company focused on discovering and developing a new class of biologic therapies called "niche modulators" that selectively target the activation of growth factors in the disease microenvironment. our initial proprietary and partnered drug discovery programs target specific growth factors, including members of the tgf-beta superfamily, which play a fundamental role in regulating cell growth and differentiation and are present in the microenvironments of significant diseases such as fibrosis, diseases of the musculoskeletal systems, and autoimmune diseases. the company’s therapeutic approach is enabled by discoveries made by scholar rock’s scientific founders—professors timothy springer, phd, and leonard zon, md, both of children's hospital boston and harvard medical school—related to the molecular mechanisms of growth factor activation. scholar rock is backed by leading life sciences investors, including polaris partners, arch venture partners, timothy s



What does Scholar Rock Corp's logo look like?

Scholar Rock Holding Corp logo

Scholar Rock Corp executives and stock owners

Scholar Rock Corp executives and other stock owners filed with the SEC include: